Hyaluronic acid/poly(amidoamine) dendrimer nanoparticles for central nervous system applications: in vitro and in vivo studies

Central nervous system (CNS) disorders are among the diseases with less efficiency in treatment. In order to reach its target and exert its effect within the brain parenchyma, drugs must overcome the blood brain barrier (BBB) and the blood-cerebrospinal fluid-brain (BCSFB). The aim of this work was...

Full description

Bibliographic Details
Main Author: Silva, Barbara L. (author)
Other Authors: Cerqueira, Susana R. (author), Fevereiro, J. P. (author), Pirraco, Rogério P. (author), Marques, A. P. (author), Oliveira, Joaquim M. (author), Reis, R. L. (author), Sousa, Nuno (author), Salgado, A. J. (author)
Format: conferenceObject
Language:eng
Published: 2012
Subjects:
Central nervous system applications
Dendrimer nanoparticles
Science & Technology
Online Access:http://hdl.handle.net/1822/23867
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/23867

Internet

http://hdl.handle.net/1822/23867

Similar Items